Struyf Sofie, Gouwy Mieke, Dillen Chris, Proost Paul, Opdenakker Ghislain, Van Damme Jo
Laboratory of Molecular Immunology, Rega Institute for Medical Research, Leuven, Belgium.
Eur J Immunol. 2005 May;35(5):1583-91. doi: 10.1002/eji.200425753.
The innate immune response against micro-organisms is mediated by phagocytes, attracted by chemokines and other G protein-coupled receptor (GPCR) ligands. Originally, we observed increased neutrophil migration by the interaction of inflammatory CXC chemokines such as IL-8/CXCL8 and granulocyte chemotactic protein (GCP)-2/CXCL6 with regakine-1, a CC chemokine constitutively present in plasma. We here demonstrate statistically significant synergy between regakine-1 and the neutrophil attractants C5a or IL-8/CXCL8 in inducing neutrophil shape change and migration under agarose. In addition, regakine-1 attracted human bone marrow granulocytes and enhanced their chemotactic response to IL-8/CXCL8 in a dose-dependent manner. Thus, plasma chemokines may regulate the number of circulating leukocytes under homeostatic conditions and may facilitate extra recruitment of bone marrow neutrophils during inflammation. Indeed, in vivo, regakine-1 provoked a mild neutrophilia in rabbits upon intravenous injection. We also observed that the CC chemokines regakine-1 and monocyte chemotactic protein-3/CCL7 as well as the CXC chemokine stromal cell-derived factor-1alpha/CXCL12 co-operated with murine GCP-2 after intraperitoneal co-administration to increase neutrophil influx in mice. These data demonstrate that inducible and constitutive GPCR ligands synergize to enhance inflammation and facilitate a more effective immune response.
针对微生物的先天性免疫反应由吞噬细胞介导,吞噬细胞被趋化因子和其他G蛋白偶联受体(GPCR)配体吸引。最初,我们观察到炎症性CXC趋化因子如IL-8/CXCL8和粒细胞趋化蛋白(GCP)-2/CXCL6与血浆中组成性存在的CC趋化因子regakine-1相互作用可增加中性粒细胞迁移。我们在此证明,regakine-1与中性粒细胞趋化剂C5a或IL-8/CXCL8之间在诱导中性粒细胞形态改变和琼脂糖下迁移方面具有统计学上显著的协同作用。此外,regakine-1吸引人类骨髓粒细胞,并以剂量依赖性方式增强它们对IL-8/CXCL8的趋化反应。因此,血浆趋化因子可能在稳态条件下调节循环白细胞的数量,并可能在炎症期间促进骨髓中性粒细胞的额外募集。事实上,在体内,静脉注射regakine-1可使兔出现轻度中性粒细胞增多。我们还观察到,CC趋化因子regakine-1和单核细胞趋化蛋白-3/CCL7以及CXC趋化因子基质细胞衍生因子-1α/CXCL12在腹腔内联合给药后与小鼠GCP-2协同作用,增加小鼠中性粒细胞流入。这些数据表明,诱导性和组成性GPCR配体协同作用以增强炎症并促进更有效的免疫反应。